Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-03-05 @ 11:37 AM
Study NCT ID:
NCT03749850
Status:
UNKNOWN
Last Update Posted:
2021-02-17
First Post:
2018-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
Sponsor:
UMC Utrecht
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
| None | Breast Cancer | View |
| None | Breast Neoplasms | View |
| None | Stage IV Breast Cancer | View |
| None | Metastatic Cancer | View |
| None | Invasive Ductal Carcinoma of Female Breast | View |
| None | Invasive Ductal Breast Cancer | View |
| None | Adenocarcinoma Breast | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | High Intensity Focused Ultrasound | View |
| None | lyso-thermosensitive liposomal doxorubicin | View |
| None | ThermoDox | View |
| None | MR-HIFU | View |
| None | mild local hyperthermia | View |
| None | local drug delivery | View |
| None | image-guided therapy | View |
| None | nanomedicine | View |
| None | liposome | View |
| None | doxorubicin | View |
| None | adriamycin | View |
| None | cyclophosphamide | View |
| None | HIFU | View |
| None | LTLD | View |
| None | hyperthermia | View |
| None | de novo stage IV | View |
| None | metastatic breast cancer | View |